Friday, May 11, 2012
Ahead of the Bell: Gilead 'Quad' pill faces review - BusinessWeek
Sydney Morning HeraldAhead of the Bell: Gilead 'Quad' pill faces reviewBusinessWeekBy AP Gilead Sciences Inc. received a positive endorsement Thursday from a panel of FDA advisors for one of its HIV treatments and will likely receive another good review Friday, according to analysts. A Food and Drug Administration panel recommended ...FDA panel backs Gilead's Truvada to prevent HIVChicago TribuneTruvada for HIV prevention backed by advisory panel, FDA may decide by JuneCBS NewsFDA
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment